Cited by 71Bariatric Surgery and OutcomesDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Calorie restriction and not glucagon‐like peptide‐1 explains the acute improvement in glucose control after gastric bypass in Type 2 diabetes

Open access
Steven, S., Hollingsworth, K. G., Small, P. K., Woodcock, S. A., Pucci, A., Aribasala, B., Al‐Mrabeh, A., Batterham, R. L. +1 more·2016·Diabetic Medicine

Abstract

Aims: To compare directly the impact of glucagon‐like peptide‐1 secretion on glucose metabolism in individuals with Type 2 diabetes listed for Roux‐en‐Y gastric bypass surgery, randomized to be studied before and 7 days after undergoing Roux‐en‐Y gastric bypass or after following a very‐low‐calorie diet. Methods: A semi‐solid meal test was used to investigate glucose, insulin and glucagon‐like peptide‐1 response. Insulin secretion in response to intravenous glucose and arginine stimulus was measured. Hepatic and pancreatic fat content was quantified using magnetic resonance imaging. Results: The decrease in fat mass was almost identical in the Roux‐en‐Y gastric bypass and the very‐low‐calorie diet groups (3.0±0.3 and 3.0±0.7kg). The early rise in plasma glucose level and in acute insulin secretion were greater after Roux‐en‐Y gastric bypass than after a very‐low‐calorie diet; however, the early rise in glucagon‐like peptide‐1 was disproportionately greater (sevenfold) after Roux‐en‐Y gastric bypass than after a very‐low‐calorie diet. This did not translate into a greater improvement in fasting glucose level or area under the curve for glucose. The reduction in liver fat was greater after Roux‐en‐Y gastric bypass (29.8±3.7 vs 18.6±4.0%) and the relationships between weight loss and reduction in liver fat differed between the Roux‐en‐Y gastric bypass group and the very‐low‐calorie diet group. Conclusions: This study shows that gastroenterostomy increases the rate of nutrient absorption, bringing about a commensurately rapid rise in insulin level; however, there was no association with the large post‐meal rise in glucagon‐like peptide‐1, and post‐meal glucose homeostasis was similar in the Roux‐en‐Y gastric bypass and very‐low‐calorie diet groups. (Clinical trials registry number: ISRCTN 11969319.)

Integrity signals

Registry

Crossref · 10.1111/dme.13257

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Steven, S., Hollingsworth, K. G., Small, P. K., Woodcock, S. A., Pucci, A., Aribasala, B., Al‐Mrabeh, A., Batterham, R. L., & Taylor, R.
Affiliations
  • Newcastle University (GB)
  • Sunderland Royal Hospital (GB)
  • North Tyneside General Hospital (GB)
  • University College London (GB)
  • Lagos State University (NG)
  • Magnetic Resonance Centre Institute of Cellular Medicine, Newcastle University Newcastle upon Tyne UK
Corresponding author
Taylor, R.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2016-10-08
Volume
33
Issue
12
Pages
1723-1731
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2511459438
Cited by
71
References
33
Citations by year
2026: 3 · 2025: 6 · 2024: 13 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 9 · 2019: 10 · 2018: 8 · 2017: 3 · 2012: 1
FWCI
7.75
Type
journal article
Language
en
Open access
Locations
  • Diabetic Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
European Foundation for the Study of Diabetes
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
Roux-en-Y gastric bypass, type 2 diabetes, glucagon-like peptide-1, very low calorie diet, caloric restriction, glucose homeostasis, insulin secretion, liver fat, weight loss, bariatric surgery, nutrient absorption
MeSH terms
Insulin Secretion, Acyltransferases, Adipose Tissue, Adult, Aged, Amino Acids, Arginine, Blood Glucose, Body Composition, Chromium, Diabetes Mellitus, Type 2, Female, Glucose, Glycated Hemoglobin, Humans, Insulin, Insulin Resistance, Lipase, Liver, Male, Membrane Proteins, Middle Aged, Nicotinic Acids, Pancreas, Triglycerides, Gastric Bypass, Caloric Restriction, Glucagon-Like Peptide 1, Phospholipases A2, Calcium-Independent

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review